Skip to main content

Day: June 18, 2025

Conexus, Cornerstone, and Synergy Credit Unions are Merging!

Together for a Thriving Saskatchewan imageMembers of Conexus, Cornerstone, and Synergy Credit Unions have voted in favour of merging, marking a historic and exciting moment for credit union members across Saskatchewan.Regina, Saskatchewan, June 18, 2025 (GLOBE NEWSWIRE) — Members of Conexus, Cornerstone, and Synergy Credit Unions have voted in favour of merging, marking a historic and exciting moment for credit union members across Saskatchewan. This pivotal moment marks the beginning of an exciting new chapter for these credit unions and the communities we serve!  Effective January 1, 2026, these three credit unions will unite to form a new province-wide credit union. The new credit union will be governed by an inaugural board that will include twelve directors comprised of six directors from Conexus and three each from...

Continue reading

Ethan Allen Day: an American Brand Celebrates Its History

DANBURY, Conn., June 18, 2025 (GLOBE NEWSWIRE) — Ethan Allen, a manufacturer and retailer of home furnishings founded in Vermont and headquartered in Danbury, Connecticut, will hold its annual Ethan Allen Day celebration on June 23. Founded in 1932, Ethan Allen opened its first sawmill in Beecher Falls, Vermont, in 1936. The company continues to manufacture furniture in Beecher Falls and Orleans, Vermont, as well as in Maiden and Claremont, North Carolina, in addition to having operations in Mexico and Honduras. Overall, the company manufactures about 75% of its furniture in North America. “When most companies moved their manufacturing overseas, we deepened our commitment to making most of our furniture close to home, as we have done for the past 93 years,” stated Farooq Kathwari, Ethan Allen’s Chairman, President, and CEO. “We’re...

Continue reading

Acme United Corporation Board Increases Cash Dividend 7 Percent to $0.16 Per Share

SHELTON, Conn., June 18, 2025 (GLOBE NEWSWIRE) — The Board of Directors of Acme United Corporation (NYSE American: ACU) declared a cash dividend of 16 cents per share on its outstanding common stock. The dividend is payable on July 24, 2025, to stockholders of record on the close of business on July 3, 2025. Walter C. Johnsen, Chairman and CEO, said, “This is Acme United’s fifteenth dividend increase since 2004. We are optimistic about our future, and we are pleased to provide this additional return to shareholders.” ACME UNITED CORPORATION is a leading worldwide supplier of innovative safety solutions and cutting technology to the school, home, office, hardware, sporting goods and industrial markets. Its leading brands include First Aid Only®, First Aid Central®, PhysiciansCare®, Spill Magic®, Westcott®, Clauss®, DMT®, Med-Nap,...

Continue reading

Bioxytran Secures a Source of GMP Quality Camel Hemoglobin

– First use of camel hemoglobin as a universal oxygen carrier – Unique properties make it an ideal ingredient for oxygen transport BOSTON, MASSACHUSETTS, June 18, 2025 (GLOBE NEWSWIRE) — BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing drugs to treat stroke, Alzheimer’s disease, and viruses, has a secured a GMP quality source of camel hemoglobin with help from the Heme Foundation. The Heme foundation, dedicated to solving the worlds blood shortages, is partnered with Bioxytran in a $10 million Joint Venture (JV) to develop a Universal Oxygen Carrier (UOC). Through this collaboration, Bioxtyran now has a long-term source of GMP quality camel hemoglobin – a crucial component for advancing this innovative oxygen transport system. Growing interest in the UOC project is expected...

Continue reading

Stardust Power Inc. Announces Closing of $4.3 Million Underwritten Public Offering

GREENWICH, CONNECTICUT, June 18, 2025 (GLOBE NEWSWIRE) — Stardust Power Inc. (NASDAQ: SDST) (the “Company”), an American developer of battery-grade lithium products, today announced the closing of its previously announced underwritten public offering. Gross proceeds to the Company were approximately $4.3 million, before deducting underwriting fees and other offering expenses payable by the Company. The offering closed on June 18, 2025. The offering consisted of 21,500,000 shares of common stock (“Common Stock”). The public offering price per share of Common Stock was $0.20. In addition, the Company has granted Aegis Capital Corp. (“Aegis”) a 45-day option to purchase up to an additional 3,225,000 shares of Common Stock, representing 15.0% of the number of shares of Common Stock sold in the offering solely to cover over-allotments,...

Continue reading

Omega Flex, Inc. Announces Regular Quarterly Dividend for the Second Quarter 2025

EXTON, Pa., June 18, 2025 (GLOBE NEWSWIRE) — Omega Flex, Inc. (the “Company”) (NASDAQ: OFLX) today announced that the Board of Directors declared a regular quarterly dividend of $0.34 per share payable on July 10, 2025, to shareholders of record on June 30, 2025.   In determining the amount of future regular quarterly dividends, the Board will review the cash needs of the Company, and based on results of operations, financial condition, capital expenditure plans, and consideration of possible acquisitions, as well as such other factors as the Board of Directors may consider relevant, determine on a quarterly basis the amount of a regular quarterly dividend. INFORMATION CONCERNING FORWARD-LOOKING STATEMENTS – This press release contains forward-looking statements, which are subject to inherent uncertainties which are difficult to...

Continue reading

Davidson Kempner Capital Management LP : Form 8.3 – Spectris PLC

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: Davidson Kempner Capital Management LP(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree Spectris PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For...

Continue reading

BOS Secures $1.1 Million Order from New Customer

RISHON LE ZION, Israel, June 18, 2025 (GLOBE NEWSWIRE) — BOS Better Online Solutions Ltd. (“BOS” or the “Company”) (NASDAQ: BOSC), a leading integrator of supply chain technologies, announced today that its Supply Chain division has secured a $1.1 million order from a new Israeli customer, with delivery scheduled for the third quarter of 2025. Avidan Zelicovsky, BOS President, stated: “Gaining this new customer highlights the strength of our Supply Chain Division in integrating franchised electromechanical components into the products of leading defense and high-tech companies. Our engineering team collaborates closely with our customers’ R&D departments to ensure seamless integration into their innovative products, supporting long-term revenue growth for us as these products move into production.” Gadi...

Continue reading

Orchestra BioMed Showcases AVIM Therapy as Purpose-Built Solution for Hypertensive Heart Disease at CSI Frankfurt 2025

Presentation underscores unique potential for atrioventricular interval modulation (“AVIM”) therapy to manage blood pressure in older, high-risk patients who have indicators of diastolic dysfunction and progression to heart failure with preserved ejection fraction (“HFpEF”) Hypertensive heart disease represents over 7.7 million U.S. patients, the same population with hypertension and elevated cardiovascular risk cited in the recent FDA Breakthrough Device Designation (“BDD”) for AVIM therapyNEW HOPE, Pa., June 18, 2025 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the presentation of key clinical insights into the role of AVIM therapy for the...

Continue reading

Icelandic Salmon AS – Minutes of Annual General Meeting 2025

The annual general meeting of Icelandic Salmon AS (the “Company”) was held on 18 June 2025 at 11:00 (CEST). All resolutions were approved as proposed by the board. Please find the minutes including appendices enclosed. The documents are also made available on the Company’s website https://arnarlax.is/investors/. For more information, please contact: Björn Hembre, CEO. Tel: +47 913 47 432 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentAGM Minutes 2025 – Icelandic Salmon AS

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.